INPLASY202590025 Post-Marketing Safety of CGRP Inhibitors: A Systematic Review Protocol of Spontaneous Reporting Data Keywords: CGRP Inhibitors; CGRP Monoclonal Antibodies; Gepants; Migraine; Pharmacovigilance; FAERS; VigiBase, EudraVigilance; Adverse Events, Drug Safety. Read and download full-text here - PDF 202590025 Review Status: ongoing
